InsiderTrades.com logo

INO Insider Trading

Insider Ownership Percentage: 2.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Inovio Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Inovio Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Inovio Pharmaceuticals Share Price & Price History

Current Price: $2.02
Price Change: +0.30 (1.20%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for INO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Inovio Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2023David B WeinerDirectorSell40$165.60$6,624.006,320View SEC Filing Icon  
2/27/2023David B WeinerDirectorSell81$184.32$14,929.926,279View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Inovio Pharmaceuticals (NASDAQ:INO)

26.79% of Inovio Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at INO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Inovio Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Jacobs Levy Equity Management Inc.17,673$41K0.0%N/A0.026%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd210,567$0.49M0.0%+855.5%0.316%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd33,496$78K0.0%-70.9%0.050%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC1,972,518$4.62M0.0%+468.7%2.956%Search for SEC Filing on Google Icon
11/17/2025Focus Partners Wealth14,289$33K0.0%N/A0.021%Search for SEC Filing on Google Icon
11/17/2025Boxer Capital Management LLC2,300,000$5.38M1.7%N/A3.447%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE636,061$1.49M0.0%-49.9%1.187%Search for SEC Filing on Google Icon
11/14/2025Zacks Investment Management19,455$46K0.0%N/A0.036%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.16,680$39K0.0%+4,396.0%0.031%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP290,800$0.68M0.0%+299.9%0.543%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG293,062$0.69M0.0%+46.8%0.551%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP443,104$1.04M0.1%+171.4%0.834%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.2,712,872$6.35M0.0%+35.0%5.105%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.65,206$0.15M0.0%+1,667.1%0.123%Search for SEC Filing on Google Icon
11/5/2025MCF Advisors LLC11,274$26K0.0%N/A0.021%Search for SEC Filing on Google Icon
10/27/2025Stephens Inc. AR13,500$32K0.0%N/A0.025%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC11,497$27K0.0%N/A0.022%Search for SEC Filing on Google Icon
10/15/2025Green Alpha Advisors LLC48,088$0.11M0.1%-9.8%0.090%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE1,270,607$2.59M0.0%-2.6%3.465%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC39,683$81K0.0%+221.2%0.108%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd115,164$0.23M0.0%N/A0.314%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd22,038$45K0.0%-66.7%0.060%Search for SEC Filing on Google Icon
8/12/2025Catalyst Funds Management Pty Ltd17,000$35K0.0%N/A0.046%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC437,549$0.89M0.0%-48.3%1.193%Search for SEC Filing on Google Icon
8/5/2025Bank of Montreal Can57,946$0.12M0.0%+23.7%0.158%Search for SEC Filing on Google Icon
8/1/2025Y Intercept Hong Kong Ltd42,171$86K0.0%N/A0.115%Search for SEC Filing on Google Icon
8/1/2025Green Alpha Advisors LLC53,308$0.11M0.1%-13.0%0.145%Search for SEC Filing on Google Icon
7/23/2025Prime Capital Investment Advisors LLC20,372$41K0.0%-32.8%0.056%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.130,534$0.21M0.0%-55.1%0.356%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.130,534$0.21M0.0%-55.1%0.356%Search for SEC Filing on Google Icon
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.20,781$34K0.0%+39.6%0.057%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC73,575$0.12M0.0%N/A0.201%Search for SEC Filing on Google Icon
5/15/2025Nomura Holdings Inc.16,871$28K0.0%N/A0.046%Search for SEC Filing on Google Icon
5/14/2025Freedom Investment Management Inc.19,170$31K0.0%N/A0.052%Search for SEC Filing on Google Icon
5/14/2025Stonepine Capital Management LLC518,331$0.85M0.8%-50.6%1.413%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC103,297$0.17M0.0%N/A0.282%Search for SEC Filing on Google Icon
5/9/2025Deutsche Bank AG39,025$64K0.0%-56.6%0.106%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.98,495$0.16M0.0%+38.6%0.269%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd66,169$0.11M0.0%+26.7%0.180%Search for SEC Filing on Google Icon
4/29/2025Concurrent Investment Advisors LLC55,011$90K0.0%N/A0.150%Search for SEC Filing on Google Icon
4/29/2025Bank of New York Mellon Corp75,422$0.12M0.0%+22.4%0.206%Search for SEC Filing on Google Icon
2/18/2025Alpine Global Management LLC16,906$31K0.0%N/A0.065%Search for SEC Filing on Google Icon
2/17/2025Stonepine Capital Management LLC1,050,000$1.92M1.6%N/A4.023%Search for SEC Filing on Google Icon
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC225,000$0.41M0.0%N/A0.862%Search for SEC Filing on Google Icon
2/17/2025Graham Capital Management L.P.62,567$0.11M0.0%N/A0.240%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG89,864$0.16M0.0%+524.6%0.344%Search for SEC Filing on Google Icon
2/17/2025Deep Track Capital LP3,119,162$5.71M0.2%+72.9%11.951%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE640,987$1.17M0.0%+1,035.2%2.456%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC39,704$73K0.0%+118.2%0.152%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp219,057$0.40M0.0%+6.4%0.839%Search for SEC Filing on Google Icon
2/14/2025Boothbay Fund Management LLC24,000$44K0.0%N/A0.092%Search for SEC Filing on Google Icon
2/14/2025Susquehanna Fundamental Investments LLC65,669$0.12M0.0%N/A0.252%Search for SEC Filing on Google Icon
2/14/2025Alpine Global Management LLC16,906$31K0.0%N/A0.065%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP79,079$0.15M0.0%-39.4%0.303%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd52,230$96K0.0%N/A0.200%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC39,114$71K0.0%+15.0%0.150%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC242,305$0.44M0.0%-26.8%0.928%Search for SEC Filing on Google Icon
2/13/2025Bank of Montreal Can23,495$43K0.0%N/A0.090%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC628,505$1.15M0.0%+1.1%2.408%Search for SEC Filing on Google Icon
2/12/2025AIGH Capital Management LLC654,115$1.20M0.4%N/A2.506%Search for SEC Filing on Google Icon
2/12/2025Highbridge Capital Management LLC300,000$0.55M0.0%N/A1.149%Search for SEC Filing on Google Icon
2/3/2025Wolverine Asset Management LLC97,400$0.18M0.0%N/A0.373%Search for SEC Filing on Google Icon
1/13/2025Green Alpha Advisors LLC65,446$0.12M0.1%+103.2%0.251%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC34,003$0.20M0.0%+282.6%0.130%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC621,631$3.59M0.0%+6.7%2.395%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC34,003$0.20M0.0%+282.6%0.131%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC18,192$0.11M0.0%-17.4%0.070%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP65,633$0.38M0.0%N/A0.253%Search for SEC Filing on Google Icon
11/15/2024State Street Corp490,662$2.84M0.0%+11.7%1.890%Search for SEC Filing on Google Icon
11/15/2024Atom Investors LP17,747$0.10M0.0%N/A0.068%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC15,167$88K0.0%+129.1%0.058%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets5,681$33K0.0%+177.0%0.022%Search for SEC Filing on Google Icon
11/13/2024FMR LLC27,261$0.16M0.0%+370.1%0.105%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC12,286$71K0.0%N/A0.047%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Fundamental Investments LLC99,991$0.81M0.0%-6.4%0.386%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company10,169$82K0.0%N/A0.039%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC410,566$3.32M0.0%-8.8%1.585%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP74,858$0.61M0.0%N/A0.289%Search for SEC Filing on Google Icon
8/8/2024Cornercap Investment Counsel Inc.22,712$0.18M0.0%N/A0.088%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.31,565$0.26M0.0%+62.2%0.122%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers38,494$0.31M0.0%+5,943.0%0.149%Search for SEC Filing on Google Icon
7/26/2024Signature Estate & Investment Advisors LLC10,876$88K0.0%N/A0.042%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp81,835$0.66M0.0%N/A0.316%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.16,497$0.23M0.0%-98.6%0.071%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD12,499$0.17M0.0%-91.7%0.053%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,594,385$22.13M0.0%-91.9%6.822%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC106,791$1.48M0.1%N/A0.457%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP79,979$1.11M0.1%-97.9%0.342%Search for SEC Filing on Google Icon
4/10/2024Green Alpha Advisors LLC36,417$0.51M0.4%-91.9%0.156%Search for SEC Filing on Google Icon
2/9/2024Keystone Financial Group122,737$63K0.0%+11.7%0.540%Search for SEC Filing on Google Icon
2/8/2024Vanguard Personalized Indexing Management LLC115,361$59K0.0%+5.6%0.507%Search for SEC Filing on Google Icon
1/5/2024Green Alpha Advisors LLC451,725$0.23M0.2%-20.8%0.165%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC460,200$0.18M0.0%N/A0.172%Search for SEC Filing on Google Icon
11/9/2023Prime Capital Investment Advisors LLC138,972$54K0.0%+213.5%0.052%Search for SEC Filing on Google Icon
11/8/2023Pathstone Family Office LLC148,392$58K0.0%+344.2%0.055%Search for SEC Filing on Google Icon
11/8/2023Vanguard Personalized Indexing Management LLC109,213$42K0.0%N/A0.041%Search for SEC Filing on Google Icon
10/27/2023Hennion & Walsh Asset Management Inc.163,562$64K0.0%-16.5%0.061%Search for SEC Filing on Google Icon
10/10/2023Green Alpha Advisors LLC570,049$0.22M0.2%+212.7%0.213%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC64,715$29K0.0%-92.5%0.024%Search for SEC Filing on Google Icon
8/7/2023Keystone Financial Group106,397$48K0.0%N/A0.040%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Inovio Pharmaceuticals logo
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.
Read More on Inovio Pharmaceuticals

Today's Range

Now: $2.02
Low: $1.96
High: $2.06

50 Day Range

MA: $2.23
Low: $1.73
High: $2.65

52 Week Range

Now: $2.02
Low: $1.30
High: $4.44

Volume

677,649 shs

Average Volume

1,158,409 shs

Market Capitalization

$134.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Who are the major institutional investors of Inovio Pharmaceuticals?

Inovio Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 5.10%
  2. Boxer Capital Management LLC — 3.45%
  3. Millennium Management LLC — 2.96%
  4. Bank of America Corp DE — 1.19%
  5. GSA Capital Partners LLP — 0.83%
  6. UBS Group AG — 0.55%
Learn More about top institutional investors of Inovio Pharmaceuticals stock.

Which major investors are selling Inovio Pharmaceuticals stock?

During the previous quarter, INO stock was sold by these institutional investors:
  1. Bank of America Corp DE
  2. Qube Research & Technologies Ltd
  3. Citadel Advisors LLC
  4. Green Alpha Advisors LLC

Which major investors are buying Inovio Pharmaceuticals stock?

During the previous quarter, INO stock was acquired by institutional investors including:
  1. Boxer Capital Management LLC
  2. Millennium Management LLC
  3. Vanguard Group Inc.
  4. GSA Capital Partners LLP
  5. Two Sigma Investments LP
  6. XTX Topco Ltd
  7. UBS Group AG
  8. JPMorgan Chase & Co.